title: von Willebrand disease type1/type 2N compound heterozygotes: diagnostic and management challenges.
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, MN, USA.
authors.forename: Juliana
authors.initials: J
authors.lastname: Perez Botero
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, MN, USA.|Special Coagulation Laboratory, Division of Hematopathology, Mayo Clinic, Rochester, MN, USA.
authors.forename: Rajiv K
authors.initials: RK
authors.lastname: Pruthi
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, MN, USA.|Special Coagulation Laboratory, Division of Hematopathology, Mayo Clinic, Rochester, MN, USA.
authors.forename: William L
authors.initials: WL
authors.lastname: Nichols
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, MN, USA.|Special Coagulation Laboratory, Division of Hematopathology, Mayo Clinic, Rochester, MN, USA.
authors.forename: Aneel A
authors.initials: AA
authors.lastname: Ashrani
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, MN, USA.
authors.forename: Mrinal M
authors.initials: MM
authors.lastname: Patnaik
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006579:Heterozygote; D006801:Humans; D008297:Male; D055815:Young Adult; D014842:von Willebrand Diseases / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*
keywords: bleeding; factor VIII; genetics of thrombosis and haemostasis; von Willebrand disease; von Willebrand factor